Palliative Radiation Therapy for Head and Neck Cancers
Patients with advanced head and neck cancers who are not eligible for curative treatment represent a challenging cohort of patients to manage given the complexity and severity of their presenting symptoms. Palliative radiation therapy, along with other systemic and surgical measures, has the potenti...
Saved in:
Published in | International journal of radiation oncology, biology, physics Vol. 105; no. 2; pp. 254 - 266 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Patients with advanced head and neck cancers who are not eligible for curative treatment represent a challenging cohort of patients to manage given the complexity and severity of their presenting symptoms. Palliative radiation therapy, along with other systemic and surgical measures, has the potential to significantly improve the quality of life of such patients. There is little high-level evidence and a lack of consensus to direct the selection of an optimal palliative radiation regimen.
An ideal palliative radiation regimen should alleviate symptoms secondary to the cancer with minimal treatment toxicity and side effects while improving a patient's quality of life. This review presents the treatment approaches, outcomes, and toxicities associated with different radiation regimens and proposes a multidisciplinary framework for the selection of an individualized treatment regimen for patients that centers around patient prognosis, goals of care, logistics of treatment, and the availability of other surgical and systemic therapies. |
---|---|
AbstractList | Patients with advanced head and neck cancers who are not eligible for curative treatment represent a challenging cohort of patients to manage given the complexity and severity of their presenting symptoms. Palliative radiation therapy, along with other systemic and surgical measures, has the potential to significantly improve the quality of life of such patients. There is little high-level evidence and a lack of consensus to direct the selection of an optimal palliative radiation regimen. An ideal palliative radiation regimen should alleviate symptoms secondary to the cancer with minimal treatment toxicity and side effects while improving a patient's quality of life. This review presents the treatment approaches, outcomes, and toxicities associated with different radiation regimens and proposes a multidisciplinary framework for the selection of an individualized treatment regimen for patients that centers around patient prognosis, goals of care, logistics of treatment, and the availability of other surgical and systemic therapies. Patients with advanced head and neck cancers who are not eligible for curative treatment represent a challenging cohort of patients to manage given the complexity and severity of their presenting symptoms. Palliative radiation therapy, along with other systemic and surgical measures, has the potential to significantly improve the quality of life of such patients. There is little high-level evidence and a lack of consensus to direct the selection of an optimal palliative radiation regimen. An ideal palliative radiation regimen should alleviate symptoms secondary to the cancer with minimal treatment toxicity and side effects while improving a patient's quality of life. This review presents the treatment approaches, outcomes, and toxicities associated with different radiation regimens and proposes a multidisciplinary framework for the selection of an individualized treatment regimen for patients that centers around patient prognosis, goals of care, logistics of treatment, and the availability of other surgical and systemic therapies. |
Author | Grewal, Amardeep S. Lin, Alexander Jones, Joshua |
Author_xml | – sequence: 1 givenname: Amardeep S. surname: Grewal fullname: Grewal, Amardeep S. – sequence: 2 givenname: Joshua surname: Jones fullname: Jones, Joshua – sequence: 3 givenname: Alexander surname: Lin fullname: Lin, Alexander email: alexander.lin@uphs.upenn.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31128145$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kE1Lw0AQhhep2A_9ByI5ekmczX4kuQhS1ApFRSp4WzabCW5Mk7qbFvrvTUn16Gnm8LzzMs-UjJq2QUIuKUQUqLypIlu5Nt9EMdAsAhFBzE_IhKZJFjIhPkZkAkxCyHp4TKbeVwBAacLPyJhRGqeUiwmRr7qure7sDoM3XRy2tglWn-j0Zh-UrQsWqItAN0XwjOYrmOvGoPPn5LTUtceL45yR94f71XwRLl8en-Z3y9DwhHdhJgEE5rGQLDOMiTwvBaayRANoUtA651TyAnWS9AwUJs9Tg5Kb1MgMTclm5Hq4u3Ht9xZ9p9bWG6xr3WC79SqOWUyppJnoUT6gxrXeOyzVxtm1dntFQR2MqUoNxtTBmAKhemN97OrYsM3XWPyFfhX1wO0AYP_nzqJT3ljsLRTWoelU0dr_G34Ao5V_gw |
CitedBy_id | crossref_primary_10_1016_j_jphotobiol_2019_111578 crossref_primary_10_3390_diagnostics13010099 crossref_primary_10_1186_s12951_021_01131_9 crossref_primary_10_1016_j_ajoms_2024_01_011 crossref_primary_10_1016_j_otc_2022_12_004 crossref_primary_10_1002_hed_26342 crossref_primary_10_1016_j_biopha_2023_114485 crossref_primary_10_1016_j_amjoto_2023_104031 crossref_primary_10_1016_j_lfs_2020_118189 crossref_primary_10_4103_jrcr_jrcr_53_21 crossref_primary_10_1016_j_radonc_2020_05_020 crossref_primary_10_3389_fonc_2021_683042 crossref_primary_10_1002_hed_26648 crossref_primary_10_1016_j_ctro_2023_100633 crossref_primary_10_3389_fonc_2022_1032471 crossref_primary_10_1007_s00066_020_01672_2 crossref_primary_10_1016_j_adro_2022_101096 crossref_primary_10_1016_j_soc_2021_02_007 crossref_primary_10_14338_IJPT_20_00060_1 crossref_primary_10_1002_hed_27730 crossref_primary_10_1200_GO_23_00253 crossref_primary_10_3389_fonc_2023_1288695 crossref_primary_10_7759_cureus_22142 crossref_primary_10_1016_j_ijrobp_2022_03_034 crossref_primary_10_1007_s00520_024_08419_0 crossref_primary_10_3389_fonc_2021_761393 crossref_primary_10_1017_S1460396922000322 crossref_primary_10_3390_medicina57010006 crossref_primary_10_5794_jjoms_69_9 crossref_primary_10_1177_08258597211065676 crossref_primary_10_1021_acsnano_1c05891 crossref_primary_10_1097_DCC_0000000000000606 crossref_primary_10_3390_cancers14030588 crossref_primary_10_1016_j_anl_2024_04_005 crossref_primary_10_6004_jnccn_2020_7664 crossref_primary_10_1002_adhm_202400406 crossref_primary_10_12968_ijpn_2022_28_7_333 crossref_primary_10_1007_s11864_023_01073_4 crossref_primary_10_1136_bmjspcare_2021_002908 crossref_primary_10_1002_pro6_1086 crossref_primary_10_1002_hed_26555 crossref_primary_10_1166_mex_2023_2578 crossref_primary_10_1093_jjco_hyac013 crossref_primary_10_1002_hed_26819 crossref_primary_10_1016_j_canrad_2023_03_004 crossref_primary_10_36290_xon_2022_064 |
Cites_doi | 10.1259/bjr.20140646 10.1016/j.ijrobp.2017.06.012 10.1016/j.radonc.2004.03.009 10.1016/j.clon.2010.09.006 10.1016/S0140-6736(18)31999-8 10.1016/j.joms.2011.02.063 10.21873/anticanres.11364 10.1016/S1368-8375(97)00073-0 10.1016/j.ijrobp.2017.04.017 10.1016/j.ijrobp.2008.09.022 10.1056/NEJMoa0802656 10.1126/sciimmunol.aag1266 10.4103/0973-1075.116709 10.1016/j.ijrobp.2016.01.039 10.1056/NEJMoa1809697 10.1002/lary.23657 10.1016/0360-3016(89)90120-X 10.1002/hed.20697 10.1016/j.coms.2014.01.001 10.1136/ewjm.172.5.310 10.2217/fon-2017-0468 10.4103/0973-1075.58460 10.1056/NEJMoa1602252 10.1002/hed.20894 10.1053/srao.2000.6593 10.1080/02841860902740899 10.3122/jabfm.2015.04.140301 10.1016/S1470-2045(14)71116-7 10.1056/NEJMoa1000678 10.1089/jpm.2006.0192 10.1200/JCO.2014.55.1937 10.1016/0360-3016(93)90012-K 10.4103/0019-509X.180847 10.1200/jco.2015.33.29_suppl.39 10.1016/j.ijrobp.2010.06.055 10.1016/j.oraloncology.2015.07.011 10.1056/NEJMoa0912217 10.1200/JCO.2006.07.9194 10.1016/j.amjoto.2018.01.011 10.1016/j.ijrobp.2010.08.029 10.1016/j.radonc.2007.10.020 10.1016/S0959-8049(00)00054-X 10.1016/j.ijrobp.2016.03.053 10.1016/j.radonc.2005.10.008 10.12788/jcso.0201 10.1016/j.ijrobp.2018.06.105 10.14338/IJPT-18-00003.1 10.1016/j.radonc.2008.06.007 10.1007/s00520-014-2421-y |
ContentType | Journal Article |
Copyright | 2019 Elsevier Inc. Copyright © 2019 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2019 Elsevier Inc. – notice: Copyright © 2019 Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.ijrobp.2019.05.024 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-355X |
EndPage | 266 |
ExternalDocumentID | 10_1016_j_ijrobp_2019_05_024 31128145 S0360301619307461 |
Genre | Journal Article Review |
GroupedDBID | --- --K .1- .FO 0R~ 1B1 1P~ 1RT 1~5 4.4 457 4G. 53G 5RE 7-5 AAEDT AAEDW AAIAV AALRI AAWTL AAXUO ABJNI ABLJU ABNEU ABOCM ABUDA ACGFS ACIUM ADBBV AENEX AEVXI AFCTW AFRHN AFTJW AGZHU AHHHB AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS ALXNB AMRAJ BELOY DU5 EBS EFJIC EJD F5P FDB GBLVA HED HMO IHE J1W KOM LX3 M41 MO0 O9- OC~ OO- RIG RNS ROL RPZ SDG SEL SES SSZ UV1 XH2 Z5R ZA5 ~S- ADVLN AKRWK CGR CUY CVF ECM EIF NPM .55 .GJ 29J 5VS AAQFI AAQQT AAQXK AAYXX ABEFU ADMUD ADPAM AFFNX AFJKZ AGRDE ASPBG AVWKF AZFZN CITATION FEDTE FGOYB FIRID G-2 HMK HVGLF HX~ HZ~ NQ- R2- SAE SEW UDS X7M XPP ZGI 7X8 |
ID | FETCH-LOGICAL-c474t-96005eb25639c335bbf5e86fec0ec80aab4164dea772560dcbb8ce64c8c69ecf3 |
ISSN | 0360-3016 |
IngestDate | Fri Aug 16 03:53:06 EDT 2024 Thu Sep 26 17:04:15 EDT 2024 Sat Sep 28 08:31:59 EDT 2024 Fri Feb 23 02:14:57 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | Copyright © 2019 Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c474t-96005eb25639c335bbf5e86fec0ec80aab4164dea772560dcbb8ce64c8c69ecf3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
OpenAccessLink | http://www.redjournal.org/article/S0360301619307461/pdf |
PMID | 31128145 |
PQID | 2232116195 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_2232116195 crossref_primary_10_1016_j_ijrobp_2019_05_024 pubmed_primary_31128145 elsevier_sciencedirect_doi_10_1016_j_ijrobp_2019_05_024 |
PublicationCentury | 2000 |
PublicationDate | 2019-10-01 2019-10-00 20191001 |
PublicationDateYYYYMMDD | 2019-10-01 |
PublicationDate_xml | – month: 10 year: 2019 text: 2019-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | International journal of radiation oncology, biology, physics |
PublicationTitleAlternate | Int J Radiat Oncol Biol Phys |
PublicationYear | 2019 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Mohanti, Umapathy, Bahadur, Thakar, Pathy (bib22) 2004; 71 Temel, Greer, Muzikansky (bib58) 2010; 363 Minatel, Gigante, Franchin (bib30) 1998; 34 Burtness B, Harrington KJ, Greil R, et al. KEYNOTE-048: Phase 3 study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Paper presented at: The European Society for Medical Oncology 2018 Congress. October 22, 2018; Munich, Germany. Bernacki, Paladino, Lamas (bib45) 2015; 33 Ghoshal, Chakraborty, Moudgil, Kaur, Patel (bib12) 2009; 15 Ferris, Gillison, Harris (bib39) 2017; 35 Siddiqui, Patel, Khan (bib33) 2009; 74 Sun, Michel, Babin (bib56) 2018; 14 Bledsoe, Noble, Reddy (bib31) 2016; 36 Murthy, Kumar, Budrukkar, Gupta, Ghosh-Laskar, Agarwal (bib19) 2016; 53 Jang, Teng, Genden (bib2) 2013; 123 Finnegan, Bhatt, Shaughnessy (bib11) 2016; 14 Spencer, Harris, Wheeler (bib50) 2008; 30 Porceddu, Rosser, Burmeister (bib18) 2007; 85 Spiotto, Fu, Weichselbaum (bib44) 2016; 1 Carrascosa, Yashar, Paris, Larocca, Faught, Spanos (bib17) 2007; 10 Palma, Olson, Harrow (bib55) 2018; 2013 Chen, Vaughan, Narayan, Vijayakumar (bib7) 2008; 30 Al-mamgani, Tans, Van rooij, Noever, Baatenburg de jong, Levendag (bib29) 2009; 48 Kowalski, Carvalho (bib4) 2000; 36 Das, Thomas, Pal, Isiah, John (bib27) 2013; 19 Cohen, Soulieres, Le Tourneau (bib37) 2019; 393 Agarwal, Nemade, Murthy (bib28) 2008; 89 Ferris, Blumenschein, Fayette (bib38) 2016; 375 McDonald, Moore, Johnstone (bib53) 2012; 82 Powell, Gitau, Sumey (bib40) 2018; 36 Ma, Lok, Zong (bib15) 2018; 4 Phan, Sio, Nguyen (bib14) 2016; 96 Gamez, Agarwal, Hu, Lukens, Harrison (bib16) 2017; 37 Paliwal, Kumar-Patidar, Walke, Hirapara, Jain, Raj-Bardia (bib23) 2012; 5 Khan, Tjong, Raziee (bib34) 2015; 23 bib59 Christakis, Lamont (bib41) 2000; 172 Ghoshal, Patel, Mudgil, Bansal, Sharma (bib24) 2004; 10 Vargo, Ward, Caudell (bib35) 2018; 100 Ward, Riaz, Caudell (bib52) 2018; 100 Nieder, Milas, Ang (bib54) 2000; 10 Moore, Mehta (bib46) 2015; 38 Visneswaran, Williams (bib1) 2014; 26 Kancherla, Oksuz, Prestwich (bib26) 2011; 23 Lok, Jiang, Gutiontov (bib13) 2015; 51 Stevens, Huang, Fung (bib36) 2011; 81 Fortin, Khaouam, Filion, Nguyen-Tan, Bujold, Lambert (bib21) 2016; 95 Spanos, Guse, Perez, Grigsby, Doggett, Poulter (bib8) 1989; 17 Fakhry, Zhang, Nguyen-Tan (bib48) 2014; 32 bib60 Ali, Alam, Mannan, Asaduzzaman, Khan, Islam (bib25) 2010; 6 Ang, Harris, Wheeler (bib47) 2010; 363 Paris, Spanos, Lindberg, Jose, Albrink (bib9) 1993; 25 Rzenwnicki, Kordecki, Lukasiewicz, Janica, Pulawska-Stalmach, Kordecki (bib3) 2012; 77 Langer, Harris, Horwitz (bib51) 2007; 25 Balachandran, Gonen, Smith, DeMatteo (bib42) 2015; 16 Corry, Peters, Costa (bib10) 2005; 77 Kawaguchi, Sato, Yamada (bib32) 2012; 70 Velez, Wang, Hsu (bib49) 2018; 39 Nguyen, Doerwald-Munoz, Zhang (bib20) 2015; 88 Antonia, Villegas, Daniel (bib43) 2018; 379 Vermorken, Mesia, Rivera (bib5) 2008; 359 Shuman, Yang, Taylor (bib57) 2011 Ali (10.1016/j.ijrobp.2019.05.024_bib25) 2010; 6 Mohanti (10.1016/j.ijrobp.2019.05.024_bib22) 2004; 71 Ferris (10.1016/j.ijrobp.2019.05.024_bib38) 2016; 375 Das (10.1016/j.ijrobp.2019.05.024_bib27) 2013; 19 Visneswaran (10.1016/j.ijrobp.2019.05.024_bib1) 2014; 26 Ghoshal (10.1016/j.ijrobp.2019.05.024_bib24) 2004; 10 Agarwal (10.1016/j.ijrobp.2019.05.024_bib28) 2008; 89 Rzenwnicki (10.1016/j.ijrobp.2019.05.024_bib3) 2012; 77 Vargo (10.1016/j.ijrobp.2019.05.024_bib35) 2018; 100 Chen (10.1016/j.ijrobp.2019.05.024_bib7) 2008; 30 Ma (10.1016/j.ijrobp.2019.05.024_bib15) 2018; 4 Fakhry (10.1016/j.ijrobp.2019.05.024_bib48) 2014; 32 Ward (10.1016/j.ijrobp.2019.05.024_bib52) 2018; 100 Phan (10.1016/j.ijrobp.2019.05.024_bib14) 2016; 96 Velez (10.1016/j.ijrobp.2019.05.024_bib49) 2018; 39 Carrascosa (10.1016/j.ijrobp.2019.05.024_bib17) 2007; 10 Porceddu (10.1016/j.ijrobp.2019.05.024_bib18) 2007; 85 Al-mamgani (10.1016/j.ijrobp.2019.05.024_bib29) 2009; 48 Kawaguchi (10.1016/j.ijrobp.2019.05.024_bib32) 2012; 70 Spiotto (10.1016/j.ijrobp.2019.05.024_bib44) 2016; 1 Christakis (10.1016/j.ijrobp.2019.05.024_bib41) 2000; 172 Sun (10.1016/j.ijrobp.2019.05.024_bib56) 2018; 14 Antonia (10.1016/j.ijrobp.2019.05.024_bib43) 2018; 379 McDonald (10.1016/j.ijrobp.2019.05.024_bib53) 2012; 82 Temel (10.1016/j.ijrobp.2019.05.024_bib58) 2010; 363 Gamez (10.1016/j.ijrobp.2019.05.024_bib16) 2017; 37 Ferris (10.1016/j.ijrobp.2019.05.024_bib39) 2017; 35 Murthy (10.1016/j.ijrobp.2019.05.024_bib19) 2016; 53 Kowalski (10.1016/j.ijrobp.2019.05.024_bib4) 2000; 36 Paris (10.1016/j.ijrobp.2019.05.024_bib9) 1993; 25 Moore (10.1016/j.ijrobp.2019.05.024_bib46) 2015; 38 Ghoshal (10.1016/j.ijrobp.2019.05.024_bib12) 2009; 15 Shuman (10.1016/j.ijrobp.2019.05.024_bib57) 2011 Kancherla (10.1016/j.ijrobp.2019.05.024_bib26) 2011; 23 Bernacki (10.1016/j.ijrobp.2019.05.024_bib45) 2015; 33 Balachandran (10.1016/j.ijrobp.2019.05.024_bib42) 2015; 16 Lok (10.1016/j.ijrobp.2019.05.024_bib13) 2015; 51 Stevens (10.1016/j.ijrobp.2019.05.024_bib36) 2011; 81 Siddiqui (10.1016/j.ijrobp.2019.05.024_bib33) 2009; 74 10.1016/j.ijrobp.2019.05.024_bib6 Khan (10.1016/j.ijrobp.2019.05.024_bib34) 2015; 23 Cohen (10.1016/j.ijrobp.2019.05.024_bib37) 2019; 393 Spencer (10.1016/j.ijrobp.2019.05.024_bib50) 2008; 30 Fortin (10.1016/j.ijrobp.2019.05.024_bib21) 2016; 95 Finnegan (10.1016/j.ijrobp.2019.05.024_bib11) 2016; 14 Ang (10.1016/j.ijrobp.2019.05.024_bib47) 2010; 363 Langer (10.1016/j.ijrobp.2019.05.024_bib51) 2007; 25 Corry (10.1016/j.ijrobp.2019.05.024_bib10) 2005; 77 Nguyen (10.1016/j.ijrobp.2019.05.024_bib20) 2015; 88 Nieder (10.1016/j.ijrobp.2019.05.024_bib54) 2000; 10 Jang (10.1016/j.ijrobp.2019.05.024_bib2) 2013; 123 Spanos (10.1016/j.ijrobp.2019.05.024_bib8) 1989; 17 Paliwal (10.1016/j.ijrobp.2019.05.024_bib23) 2012; 5 Vermorken (10.1016/j.ijrobp.2019.05.024_bib5) 2008; 359 Palma (10.1016/j.ijrobp.2019.05.024_bib55) 2018; 2013 Minatel (10.1016/j.ijrobp.2019.05.024_bib30) 1998; 34 Powell (10.1016/j.ijrobp.2019.05.024_bib40) 2018; 36 Bledsoe (10.1016/j.ijrobp.2019.05.024_bib31) 2016; 36 |
References_xml | – volume: 10 start-page: 19 year: 2004 end-page: 23 ident: bib24 article-title: Palliative radiotherapy in locally advanced head and neck cancer-A prospective trial publication-title: Indian J Palliat Care contributor: fullname: Sharma – volume: 4 start-page: 10 year: 2018 end-page: 19 ident: bib15 article-title: Proton radiotherapy for recurrent or metastatic head and neck cancers with palliative quad shot publication-title: Int J Part Ther contributor: fullname: Zong – volume: 71 start-page: 275 year: 2004 end-page: 280 ident: bib22 article-title: Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study publication-title: Radiother Oncol contributor: fullname: Pathy – volume: 363 start-page: 733 year: 2010 end-page: 742 ident: bib58 article-title: Early palliative care for patients with metastatic non-small-cell lung cancer publication-title: N Engl J Med contributor: fullname: Muzikansky – volume: 363 start-page: 24 year: 2010 end-page: 35 ident: bib47 article-title: Human papillomavirus and survival of patients with oropharyngeal cancer publication-title: N Engl J Med contributor: fullname: Wheeler – volume: 36 start-page: 6010 year: 2018 ident: bib40 article-title: Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) publication-title: J Clin Oncol contributor: fullname: Sumey – volume: 100 start-page: 586 year: 2018 end-page: 594 ident: bib52 article-title: Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: A multi-institution cohort study by the MIRI collaborative publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Caudell – volume: 33 start-page: 39 year: 2015 ident: bib45 article-title: Delivering more, earlier, and better goals-of-care conversations to seriously ill oncology patients publication-title: J Clin Oncol contributor: fullname: Lamas – volume: 82 start-page: 1083 year: 2012 end-page: 1089 ident: bib53 article-title: Risk of carotid blowout after reirradiation of the head and neck: A systematic review publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Johnstone – volume: 359 start-page: 1116 year: 2008 end-page: 1127 ident: bib5 article-title: Platinum-based chemotherapy plus cetuximab in head and neck cancer publication-title: N Engl J Med contributor: fullname: Rivera – volume: 96 start-page: 30 year: 2016 end-page: 41 ident: bib14 article-title: Reirradiation of head and neck cancers with proton therapy: Outcomes and analyses publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Nguyen – volume: 34 start-page: 119 year: 1998 end-page: 122 ident: bib30 article-title: Combined radiotherapy and bleomycin in patients with inoperable head and neck cancer with unfavorable prognostic factors and severe symptoms publication-title: Oral Oncol contributor: fullname: Franchin – volume: 100 start-page: 595 year: 2018 end-page: 605 ident: bib35 article-title: A multi-institutional comparison of SBRT and IMRT for definitive reirradiation of recurrent or second primary head and neck cancer publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Caudell – volume: 379 start-page: 2342 year: 2018 end-page: 2350 ident: bib43 article-title: Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC publication-title: N Engl J Med contributor: fullname: Daniel – volume: 16 start-page: 173 year: 2015 end-page: 180 ident: bib42 article-title: Nomograms in oncology- more than meets the eye publication-title: Lancet Oncol contributor: fullname: DeMatteo – volume: 70 start-page: 461 year: 2012 end-page: 472 ident: bib32 article-title: Stereotactic radiosurgery in combination with chemotherapy as primary treatment for head and neck cancer publication-title: J Oral Maxillofac Surg contributor: fullname: Yamada – volume: 30 start-page: 281 year: 2008 end-page: 288 ident: bib50 article-title: Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck publication-title: Head Neck contributor: fullname: Wheeler – ident: bib60 article-title: Proton re-irradiation for recurrent head and neck cancer – volume: 88 start-page: 20140646 year: 2015 ident: bib20 article-title: 0-7-21 hypofractionated palliative radiotherapy: An effective treatment for advanced head and neck cancers publication-title: Br J Radiol contributor: fullname: Zhang – volume: 85 start-page: 456 year: 2007 end-page: 462 ident: bib18 article-title: Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment – “Hypo Trial publication-title: Radiother Oncol contributor: fullname: Burmeister – volume: 26 start-page: 123 year: 2014 end-page: 141 ident: bib1 article-title: Epidemiological trends in head and neck cancer and aids in diagnosis publication-title: Oral Maxillofac Surg Clin North Am contributor: fullname: Williams – volume: 37 start-page: 685 year: 2017 end-page: 691 ident: bib16 article-title: Hypofractionated palliative radiotherapy with concurrent radiosensitizing chemotherapy for advanced head and neck cancer using the “QUAD-SHOT regimen publication-title: Anticancer Res contributor: fullname: Harrison – volume: 10 start-page: 877 year: 2007 end-page: 881 ident: bib17 article-title: Palliation of pelvic and head and neck cancer with paclitaxel and a novel radiotherapy regimen publication-title: J Palliat Med contributor: fullname: Spanos – volume: 10 start-page: 200 year: 2000 end-page: 209 ident: bib54 article-title: Tissue tolerance to reirradiation publication-title: Sem Radiat Oncol contributor: fullname: Ang – volume: 30 start-page: 1586 year: 2008 end-page: 1591 ident: bib7 article-title: Palliative radiation therapy for head and neck cancer: Toward an optimal fractionation scheme publication-title: Head Neck contributor: fullname: Vijayakumar – volume: 5 start-page: 178 year: 2012 end-page: 182 ident: bib23 article-title: Palliative hypo-fractionated radiotherapy in locally advanced head and neck cancer with fixed neck nodes publication-title: Iran J Cancer Prev contributor: fullname: Raj-Bardia – volume: 23 start-page: 1099 year: 2015 end-page: 1103 ident: bib34 article-title: Role of stereotactic body radiotherapy for symptom control in head and neck cancer patients publication-title: Support Care Cancer contributor: fullname: Raziee – volume: 77 start-page: 137 year: 2005 end-page: 142 ident: bib10 article-title: The “QUAD SHOT”—a phase II study of palliative radiotherapy for incurable head and neck cancer publication-title: Radiother Oncol contributor: fullname: Costa – volume: 23 start-page: 141 year: 2011 end-page: 148 ident: bib26 article-title: The role of split-course hypofractionated palliative radiotherapy in head and neck cancer publication-title: ( contributor: fullname: Prestwich – volume: 48 start-page: 562 year: 2009 end-page: 570 ident: bib29 article-title: Hypofractionated radiotherapy denoted as the “Christie scheme”: An effective means of palliating patients with head and neck cancers not suitable for curative treatment publication-title: Acta Oncol contributor: fullname: Levendag – volume: 375 start-page: 1856 year: 2016 end-page: 1867 ident: bib38 article-title: Nivolumab for recurrent squamous-cell carcinoma of the head and neck publication-title: N Engl J Med contributor: fullname: Fayette – volume: 89 start-page: 51 year: 2008 end-page: 56 ident: bib28 article-title: Hypofractionated, palliative radiotherapy for advanced head and neck cancer publication-title: Radiother Oncol contributor: fullname: Murthy – volume: 25 start-page: 4800 year: 2007 end-page: 4805 ident: bib51 article-title: Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Protocol 9911 publication-title: J Clin Oncol contributor: fullname: Horwitz – ident: bib59 article-title: Study of proton SBRT and immunotherapy for reccurent/progressive locoregional or metastatic head and neck cancer – volume: 81 start-page: 958 year: 2011 end-page: 963 ident: bib36 article-title: Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Fung – volume: 1 start-page: 1266 year: 2016 ident: bib44 article-title: The intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications publication-title: Science Immunol contributor: fullname: Weichselbaum – volume: 14 start-page: 29 year: 2016 end-page: 36 ident: bib11 article-title: Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: Institutional experience and review of palliative regimens publication-title: J Community Support Oncol contributor: fullname: Shaughnessy – volume: 77 start-page: 17 year: 2012 end-page: 21 ident: bib3 article-title: Palliative embolization of hemorrhages in extensive head and neck tumors publication-title: Pol J Radiol contributor: fullname: Kordecki – volume: 14 start-page: 877 year: 2018 end-page: 889 ident: bib56 article-title: Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC publication-title: Future Oncol contributor: fullname: Babin – volume: 35 start-page: 6011 year: 2017 ident: bib39 article-title: Safety evaluation of nivolumab concomitant with cetuximab-radiotherapy for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG 3504 publication-title: J Clin Oncol contributor: fullname: Harris – volume: 123 start-page: 1173 year: 2013 end-page: 1177 ident: bib2 article-title: Palliative surgery for head and neck cancer with extensive skin involvement publication-title: Laryngoscope contributor: fullname: Genden – volume: 393 start-page: 156 year: 2019 end-page: 167 ident: bib37 article-title: Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): A randomized, open-label, phase 3 study publication-title: Lancet contributor: fullname: Le Tourneau – volume: 2013 start-page: S3 year: 2018 end-page: S4 ident: bib55 article-title: Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): Results of a randomized trial publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Harrow – volume: 172 start-page: 310 year: 2000 end-page: 313 ident: bib41 article-title: Extent and determinants of error in physicians’ prognoses in terminally ill patients publication-title: West J Med contributor: fullname: Lamont – volume: 36 start-page: 1032 year: 2000 end-page: 1037 ident: bib4 article-title: Natural history of untreated head and neck cancer publication-title: Eur J Cancer contributor: fullname: Carvalho – volume: 38 start-page: 498 year: 2015 end-page: 503 ident: bib46 article-title: The growing epidemic of HPV-positive oropharyngeal carcinoma: A clinical review for primary care providers publication-title: J Am Board Fam Med contributor: fullname: Mehta – volume: 53 start-page: 138 year: 2016 end-page: 141 ident: bib19 article-title: Twice-weekly palliative radiotherapy for locally very advanced head and neck cancers publication-title: Indian J Cancer contributor: fullname: Agarwal – volume: 51 start-page: 957 year: 2015 end-page: 962 ident: bib13 article-title: Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers publication-title: Oral Oncol contributor: fullname: Gutiontov – volume: 95 start-page: 647 year: 2016 end-page: 653 ident: bib21 article-title: Palliative radiation therapy for advanced head and neck carcinomas: A phase 2 study publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Lambert – start-page: 144 year: 2011 ident: bib57 article-title: End of life care among head and neck cancer patients publication-title: Otolaryngol Head Neck Surg contributor: fullname: Taylor – volume: 19 start-page: 93 year: 2013 end-page: 98 ident: bib27 article-title: Hypofractionated palliative radiotherapy in locally advanced inoperable head and neck cancer: CMC Vellore experience publication-title: Indian J Palliat Care contributor: fullname: John – volume: 74 start-page: 1047 year: 2009 end-page: 1053 ident: bib33 article-title: Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Khan – volume: 25 start-page: 657 year: 1993 end-page: 660 ident: bib9 article-title: Phase I-II study of multiple daily fractions for palliation of advanced head and neck malignancies publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Albrink – volume: 6 start-page: 5 year: 2010 ident: bib25 article-title: Short course palliative radiotherapy in locally advanced squamous cell carcinoma of head and neck publication-title: J Armed Forces Med Coll contributor: fullname: Islam – volume: 39 start-page: 257 year: 2018 end-page: 260 ident: bib49 article-title: Prognostic significance of HPV status in re-irradiation of recurrent and second primary cancers of the head and neck publication-title: Am J Otolaryngol contributor: fullname: Hsu – volume: 17 start-page: 659 year: 1989 end-page: 661 ident: bib8 article-title: Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: Preliminary report of RTOG 8502 publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Poulter – volume: 32 start-page: 3365 year: 2014 end-page: 3373 ident: bib48 article-title: Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma publication-title: J Clin Oncol contributor: fullname: Nguyen-Tan – volume: 36 start-page: 933 year: 2016 end-page: 939 ident: bib31 article-title: Split-course accelerated hypofractionated radiotherapy (SCHART): A safe and effective option for head and neck cancer in the elderly or infirm publication-title: Anticancer Res contributor: fullname: Reddy – volume: 15 start-page: 137 year: 2009 end-page: 140 ident: bib12 article-title: Quad shot: A short but effective schedule for palliative radiation for head and neck carcinoma publication-title: Indian J Palliat Care contributor: fullname: Patel – volume: 88 start-page: 20140646 year: 2015 ident: 10.1016/j.ijrobp.2019.05.024_bib20 article-title: 0-7-21 hypofractionated palliative radiotherapy: An effective treatment for advanced head and neck cancers publication-title: Br J Radiol doi: 10.1259/bjr.20140646 contributor: fullname: Nguyen – ident: 10.1016/j.ijrobp.2019.05.024_bib6 – volume: 100 start-page: 586 year: 2018 ident: 10.1016/j.ijrobp.2019.05.024_bib52 article-title: Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: A multi-institution cohort study by the MIRI collaborative publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2017.06.012 contributor: fullname: Ward – volume: 71 start-page: 275 year: 2004 ident: 10.1016/j.ijrobp.2019.05.024_bib22 article-title: Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study publication-title: Radiother Oncol doi: 10.1016/j.radonc.2004.03.009 contributor: fullname: Mohanti – volume: 23 start-page: 141 year: 2011 ident: 10.1016/j.ijrobp.2019.05.024_bib26 article-title: The role of split-course hypofractionated palliative radiotherapy in head and neck cancer publication-title: Clin Oncol (R Coll Radiol). doi: 10.1016/j.clon.2010.09.006 contributor: fullname: Kancherla – volume: 393 start-page: 156 year: 2019 ident: 10.1016/j.ijrobp.2019.05.024_bib37 article-title: Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): A randomized, open-label, phase 3 study publication-title: Lancet doi: 10.1016/S0140-6736(18)31999-8 contributor: fullname: Cohen – volume: 70 start-page: 461 year: 2012 ident: 10.1016/j.ijrobp.2019.05.024_bib32 article-title: Stereotactic radiosurgery in combination with chemotherapy as primary treatment for head and neck cancer publication-title: J Oral Maxillofac Surg doi: 10.1016/j.joms.2011.02.063 contributor: fullname: Kawaguchi – volume: 37 start-page: 685 year: 2017 ident: 10.1016/j.ijrobp.2019.05.024_bib16 article-title: Hypofractionated palliative radiotherapy with concurrent radiosensitizing chemotherapy for advanced head and neck cancer using the “QUAD-SHOT regimen publication-title: Anticancer Res doi: 10.21873/anticanres.11364 contributor: fullname: Gamez – volume: 34 start-page: 119 year: 1998 ident: 10.1016/j.ijrobp.2019.05.024_bib30 article-title: Combined radiotherapy and bleomycin in patients with inoperable head and neck cancer with unfavorable prognostic factors and severe symptoms publication-title: Oral Oncol doi: 10.1016/S1368-8375(97)00073-0 contributor: fullname: Minatel – volume: 100 start-page: 595 year: 2018 ident: 10.1016/j.ijrobp.2019.05.024_bib35 article-title: A multi-institutional comparison of SBRT and IMRT for definitive reirradiation of recurrent or second primary head and neck cancer publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2017.04.017 contributor: fullname: Vargo – volume: 74 start-page: 1047 year: 2009 ident: 10.1016/j.ijrobp.2019.05.024_bib33 article-title: Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2008.09.022 contributor: fullname: Siddiqui – volume: 359 start-page: 1116 year: 2008 ident: 10.1016/j.ijrobp.2019.05.024_bib5 article-title: Platinum-based chemotherapy plus cetuximab in head and neck cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa0802656 contributor: fullname: Vermorken – volume: 1 start-page: 1266 year: 2016 ident: 10.1016/j.ijrobp.2019.05.024_bib44 article-title: The intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications publication-title: Science Immunol doi: 10.1126/sciimmunol.aag1266 contributor: fullname: Spiotto – volume: 19 start-page: 93 year: 2013 ident: 10.1016/j.ijrobp.2019.05.024_bib27 article-title: Hypofractionated palliative radiotherapy in locally advanced inoperable head and neck cancer: CMC Vellore experience publication-title: Indian J Palliat Care doi: 10.4103/0973-1075.116709 contributor: fullname: Das – volume: 95 start-page: 647 year: 2016 ident: 10.1016/j.ijrobp.2019.05.024_bib21 article-title: Palliative radiation therapy for advanced head and neck carcinomas: A phase 2 study publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2016.01.039 contributor: fullname: Fortin – volume: 379 start-page: 2342 year: 2018 ident: 10.1016/j.ijrobp.2019.05.024_bib43 article-title: Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC publication-title: N Engl J Med doi: 10.1056/NEJMoa1809697 contributor: fullname: Antonia – volume: 5 start-page: 178 year: 2012 ident: 10.1016/j.ijrobp.2019.05.024_bib23 article-title: Palliative hypo-fractionated radiotherapy in locally advanced head and neck cancer with fixed neck nodes publication-title: Iran J Cancer Prev contributor: fullname: Paliwal – volume: 123 start-page: 1173 year: 2013 ident: 10.1016/j.ijrobp.2019.05.024_bib2 article-title: Palliative surgery for head and neck cancer with extensive skin involvement publication-title: Laryngoscope doi: 10.1002/lary.23657 contributor: fullname: Jang – volume: 17 start-page: 659 year: 1989 ident: 10.1016/j.ijrobp.2019.05.024_bib8 article-title: Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: Preliminary report of RTOG 8502 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/0360-3016(89)90120-X contributor: fullname: Spanos – volume: 30 start-page: 281 year: 2008 ident: 10.1016/j.ijrobp.2019.05.024_bib50 article-title: Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck publication-title: Head Neck doi: 10.1002/hed.20697 contributor: fullname: Spencer – volume: 26 start-page: 123 year: 2014 ident: 10.1016/j.ijrobp.2019.05.024_bib1 article-title: Epidemiological trends in head and neck cancer and aids in diagnosis publication-title: Oral Maxillofac Surg Clin North Am doi: 10.1016/j.coms.2014.01.001 contributor: fullname: Visneswaran – volume: 172 start-page: 310 year: 2000 ident: 10.1016/j.ijrobp.2019.05.024_bib41 article-title: Extent and determinants of error in physicians’ prognoses in terminally ill patients publication-title: West J Med doi: 10.1136/ewjm.172.5.310 contributor: fullname: Christakis – volume: 14 start-page: 877 year: 2018 ident: 10.1016/j.ijrobp.2019.05.024_bib56 article-title: Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC publication-title: Future Oncol doi: 10.2217/fon-2017-0468 contributor: fullname: Sun – volume: 15 start-page: 137 year: 2009 ident: 10.1016/j.ijrobp.2019.05.024_bib12 article-title: Quad shot: A short but effective schedule for palliative radiation for head and neck carcinoma publication-title: Indian J Palliat Care doi: 10.4103/0973-1075.58460 contributor: fullname: Ghoshal – volume: 375 start-page: 1856 year: 2016 ident: 10.1016/j.ijrobp.2019.05.024_bib38 article-title: Nivolumab for recurrent squamous-cell carcinoma of the head and neck publication-title: N Engl J Med doi: 10.1056/NEJMoa1602252 contributor: fullname: Ferris – volume: 30 start-page: 1586 year: 2008 ident: 10.1016/j.ijrobp.2019.05.024_bib7 article-title: Palliative radiation therapy for head and neck cancer: Toward an optimal fractionation scheme publication-title: Head Neck doi: 10.1002/hed.20894 contributor: fullname: Chen – volume: 10 start-page: 200 year: 2000 ident: 10.1016/j.ijrobp.2019.05.024_bib54 article-title: Tissue tolerance to reirradiation publication-title: Sem Radiat Oncol doi: 10.1053/srao.2000.6593 contributor: fullname: Nieder – volume: 48 start-page: 562 year: 2009 ident: 10.1016/j.ijrobp.2019.05.024_bib29 article-title: Hypofractionated radiotherapy denoted as the “Christie scheme”: An effective means of palliating patients with head and neck cancers not suitable for curative treatment publication-title: Acta Oncol doi: 10.1080/02841860902740899 contributor: fullname: Al-mamgani – volume: 38 start-page: 498 year: 2015 ident: 10.1016/j.ijrobp.2019.05.024_bib46 article-title: The growing epidemic of HPV-positive oropharyngeal carcinoma: A clinical review for primary care providers publication-title: J Am Board Fam Med doi: 10.3122/jabfm.2015.04.140301 contributor: fullname: Moore – volume: 77 start-page: 17 year: 2012 ident: 10.1016/j.ijrobp.2019.05.024_bib3 article-title: Palliative embolization of hemorrhages in extensive head and neck tumors publication-title: Pol J Radiol contributor: fullname: Rzenwnicki – volume: 16 start-page: 173 year: 2015 ident: 10.1016/j.ijrobp.2019.05.024_bib42 article-title: Nomograms in oncology- more than meets the eye publication-title: Lancet Oncol doi: 10.1016/S1470-2045(14)71116-7 contributor: fullname: Balachandran – volume: 363 start-page: 733 year: 2010 ident: 10.1016/j.ijrobp.2019.05.024_bib58 article-title: Early palliative care for patients with metastatic non-small-cell lung cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1000678 contributor: fullname: Temel – volume: 10 start-page: 877 year: 2007 ident: 10.1016/j.ijrobp.2019.05.024_bib17 article-title: Palliation of pelvic and head and neck cancer with paclitaxel and a novel radiotherapy regimen publication-title: J Palliat Med doi: 10.1089/jpm.2006.0192 contributor: fullname: Carrascosa – volume: 36 start-page: 6010 year: 2018 ident: 10.1016/j.ijrobp.2019.05.024_bib40 article-title: Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) publication-title: J Clin Oncol contributor: fullname: Powell – start-page: 144 year: 2011 ident: 10.1016/j.ijrobp.2019.05.024_bib57 article-title: End of life care among head and neck cancer patients publication-title: Otolaryngol Head Neck Surg contributor: fullname: Shuman – volume: 32 start-page: 3365 year: 2014 ident: 10.1016/j.ijrobp.2019.05.024_bib48 article-title: Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma publication-title: J Clin Oncol doi: 10.1200/JCO.2014.55.1937 contributor: fullname: Fakhry – volume: 25 start-page: 657 year: 1993 ident: 10.1016/j.ijrobp.2019.05.024_bib9 article-title: Phase I-II study of multiple daily fractions for palliation of advanced head and neck malignancies publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/0360-3016(93)90012-K contributor: fullname: Paris – volume: 53 start-page: 138 year: 2016 ident: 10.1016/j.ijrobp.2019.05.024_bib19 article-title: Twice-weekly palliative radiotherapy for locally very advanced head and neck cancers publication-title: Indian J Cancer doi: 10.4103/0019-509X.180847 contributor: fullname: Murthy – volume: 33 start-page: 39 year: 2015 ident: 10.1016/j.ijrobp.2019.05.024_bib45 article-title: Delivering more, earlier, and better goals-of-care conversations to seriously ill oncology patients publication-title: J Clin Oncol doi: 10.1200/jco.2015.33.29_suppl.39 contributor: fullname: Bernacki – volume: 10 start-page: 19 year: 2004 ident: 10.1016/j.ijrobp.2019.05.024_bib24 article-title: Palliative radiotherapy in locally advanced head and neck cancer-A prospective trial publication-title: Indian J Palliat Care contributor: fullname: Ghoshal – volume: 81 start-page: 958 year: 2011 ident: 10.1016/j.ijrobp.2019.05.024_bib36 article-title: Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2010.06.055 contributor: fullname: Stevens – volume: 51 start-page: 957 year: 2015 ident: 10.1016/j.ijrobp.2019.05.024_bib13 article-title: Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2015.07.011 contributor: fullname: Lok – volume: 363 start-page: 24 year: 2010 ident: 10.1016/j.ijrobp.2019.05.024_bib47 article-title: Human papillomavirus and survival of patients with oropharyngeal cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa0912217 contributor: fullname: Ang – volume: 25 start-page: 4800 year: 2007 ident: 10.1016/j.ijrobp.2019.05.024_bib51 article-title: Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Protocol 9911 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.07.9194 contributor: fullname: Langer – volume: 39 start-page: 257 year: 2018 ident: 10.1016/j.ijrobp.2019.05.024_bib49 article-title: Prognostic significance of HPV status in re-irradiation of recurrent and second primary cancers of the head and neck publication-title: Am J Otolaryngol doi: 10.1016/j.amjoto.2018.01.011 contributor: fullname: Velez – volume: 82 start-page: 1083 year: 2012 ident: 10.1016/j.ijrobp.2019.05.024_bib53 article-title: Risk of carotid blowout after reirradiation of the head and neck: A systematic review publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2010.08.029 contributor: fullname: McDonald – volume: 85 start-page: 456 year: 2007 ident: 10.1016/j.ijrobp.2019.05.024_bib18 article-title: Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment – “Hypo Trial publication-title: Radiother Oncol doi: 10.1016/j.radonc.2007.10.020 contributor: fullname: Porceddu – volume: 36 start-page: 1032 year: 2000 ident: 10.1016/j.ijrobp.2019.05.024_bib4 article-title: Natural history of untreated head and neck cancer publication-title: Eur J Cancer doi: 10.1016/S0959-8049(00)00054-X contributor: fullname: Kowalski – volume: 96 start-page: 30 year: 2016 ident: 10.1016/j.ijrobp.2019.05.024_bib14 article-title: Reirradiation of head and neck cancers with proton therapy: Outcomes and analyses publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2016.03.053 contributor: fullname: Phan – volume: 36 start-page: 933 year: 2016 ident: 10.1016/j.ijrobp.2019.05.024_bib31 article-title: Split-course accelerated hypofractionated radiotherapy (SCHART): A safe and effective option for head and neck cancer in the elderly or infirm publication-title: Anticancer Res contributor: fullname: Bledsoe – volume: 77 start-page: 137 year: 2005 ident: 10.1016/j.ijrobp.2019.05.024_bib10 article-title: The “QUAD SHOT”—a phase II study of palliative radiotherapy for incurable head and neck cancer publication-title: Radiother Oncol doi: 10.1016/j.radonc.2005.10.008 contributor: fullname: Corry – volume: 14 start-page: 29 year: 2016 ident: 10.1016/j.ijrobp.2019.05.024_bib11 article-title: Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: Institutional experience and review of palliative regimens publication-title: J Community Support Oncol doi: 10.12788/jcso.0201 contributor: fullname: Finnegan – volume: 35 start-page: 6011 year: 2017 ident: 10.1016/j.ijrobp.2019.05.024_bib39 article-title: Safety evaluation of nivolumab concomitant with cetuximab-radiotherapy for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG 3504 publication-title: J Clin Oncol contributor: fullname: Ferris – volume: 2013 start-page: S3 year: 2018 ident: 10.1016/j.ijrobp.2019.05.024_bib55 article-title: Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): Results of a randomized trial publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2018.06.105 contributor: fullname: Palma – volume: 4 start-page: 10 year: 2018 ident: 10.1016/j.ijrobp.2019.05.024_bib15 article-title: Proton radiotherapy for recurrent or metastatic head and neck cancers with palliative quad shot publication-title: Int J Part Ther doi: 10.14338/IJPT-18-00003.1 contributor: fullname: Ma – volume: 89 start-page: 51 year: 2008 ident: 10.1016/j.ijrobp.2019.05.024_bib28 article-title: Hypofractionated, palliative radiotherapy for advanced head and neck cancer publication-title: Radiother Oncol doi: 10.1016/j.radonc.2008.06.007 contributor: fullname: Agarwal – volume: 6 start-page: 5 year: 2010 ident: 10.1016/j.ijrobp.2019.05.024_bib25 article-title: Short course palliative radiotherapy in locally advanced squamous cell carcinoma of head and neck publication-title: J Armed Forces Med Coll contributor: fullname: Ali – volume: 23 start-page: 1099 year: 2015 ident: 10.1016/j.ijrobp.2019.05.024_bib34 article-title: Role of stereotactic body radiotherapy for symptom control in head and neck cancer patients publication-title: Support Care Cancer doi: 10.1007/s00520-014-2421-y contributor: fullname: Khan |
SSID | ssj0001174 |
Score | 2.5652385 |
SecondaryResourceType | review_article |
Snippet | Patients with advanced head and neck cancers who are not eligible for curative treatment represent a challenging cohort of patients to manage given the... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 254 |
SubjectTerms | Cancer Pain - drug therapy Cancer Pain - radiotherapy Clinical Trials as Topic Deglutition Disorders - therapy Dose Fractionation, Radiation Episode of Care Head and Neck Neoplasms - complications Head and Neck Neoplasms - mortality Head and Neck Neoplasms - radiotherapy Humans Immunotherapy - methods Oropharyngeal Neoplasms - virology Palliative Care - methods Papillomavirus Infections - complications Physical Functional Performance Prognosis Proton Therapy Radiation-Sensitizing Agents - therapeutic use Radiotherapy - methods Radiotherapy Dosage Re-Irradiation Treatment Outcome Xerostomia - etiology |
Title | Palliative Radiation Therapy for Head and Neck Cancers |
URI | https://dx.doi.org/10.1016/j.ijrobp.2019.05.024 https://www.ncbi.nlm.nih.gov/pubmed/31128145 https://search.proquest.com/docview/2232116195 |
Volume | 105 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZC2MvZe1u6baiwd6Giy1LvjyW0i5t02wUh-VNWLJMl9KkpAmF_vodXSy7dKWXFxMMFuGcj3O-cxVC3yURuqkxgSAnqgNgxCTIJauDVDvPSsa0MnnI01EyGNPjCZv0ekedrqXVUuzK2__OlbxEq_AO9KqnZJ-hWX8ovIDfoF94gobh-SQd_y51ssQ0_5zpHQNGl4XdE2D6BwegQVMeGCl58WNfa9hVb6ZtB3ubEOyskVj48-Yz6SdaRDvcYlMinpH_XKib0hb8LwF0Sl21SVV_H8Dx_Pp85f3A0K0vaEZsugmIKPetbOA_rNHM0jwA3jK5Y1VD1oEP6dpIuzXauVtiL125Z8ltUmG6-3e6mAu9WDTKzYpVQlvP1VTrR7_44Xg45MXBpHiF1gnYHDB263snZ39OvFuOIPZqZidNg9_9kx_iJg_FHoaDFG_Rhgse8J5FwibqqdkWen3q2iPeoaQFBPaAwA4QGACBNSAwSBtrQGAHiPdofHhQ7A8CdzFGIGlKlwFEnSFTAthqnMs4ZkLUTGVJrWSoZBaWpQCaTStVQugEjLaSQmRSJVRmMsmVrOMPaG0Gqv-EMJNVquooFCQFn6nyLE5oKanZX52ShPRR0IiEX9n9J7xpDJxyK0KuRchDxkGEfZQ2cuOOw1luxkGxj3z5rREzBxOn61blTM1X1xwYLIkgMslZH3208vf_JY50KZiy7Sd8_Rm9afH7Ba0tFyv1FSjlUuw4sPwDpP141A |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Palliative+Radiation+Therapy+for+Head+and+Neck+Cancers&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=Grewal%2C+Amardeep+S&rft.au=Jones%2C+Joshua&rft.au=Lin%2C+Alexander&rft.date=2019-10-01&rft.eissn=1879-355X&rft.volume=105&rft.issue=2&rft.spage=254&rft.epage=266&rft_id=info:doi/10.1016%2Fj.ijrobp.2019.05.024&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0360-3016&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0360-3016&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0360-3016&client=summon |